| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASTH | Common Stock | Award | $0 | +13.3K | +3.34% | $0.00 | 412K | Nov 8, 2024 | Direct | F2 |
| transaction | ASTH | Common Stock | Award | $0 | +26.7K | +6.47% | $0.00 | 439K | Nov 8, 2024 | Direct | F3, F4 |
| holding | ASTH | Common Stock | 1.11M | Nov 8, 2024 | By the Thomas and Jeanette Lam 2002 Family Trust | ||||||
| holding | ASTH | Common Stock | 7.13M | Nov 8, 2024 | By Allied Physicians of California, a Professional Medical Corporation | F1 |
| Id | Content |
|---|---|
| F1 | These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F2 | Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors. |
| F3 | Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 50%, 25% and 25%, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee. |
| F4 | Includes 130,000 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 43,333 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; and (ii) grants of 30,000 shares, 30,000 shares and 26,667 shares, each of which will vest upon achievement of certain pre-established performance goals. |